(Q43244550)

17 November 2017

N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepatocellular carcinoma (English)

1 reference

17 November 2017

1 reference

Meng Fang

1

1 reference

17 November 2017

Yun-Peng Zhao

2

1 reference

17 November 2017

Fei-Guo Zhou

3

1 reference

17 November 2017

Lun-Gen Lu

4

1 reference

17 November 2017

Peng Qi

5

1 reference

17 November 2017

Hao Wang

6

1 reference

17 November 2017

Kun Zhou

7

1 reference

17 November 2017

Shu-Han Sun

8

1 reference

17 November 2017

Cui-Ying Chen

9

1 reference

17 November 2017

Chun-Fang Gao

10

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

International Journal of Cancer

17 November 2017

1 reference

17 November 2017

127

1 reference

17 November 2017

1

1 reference

17 November 2017

148-159

1 reference

Chronic hepatitis B virus infection in Asian countries

17 November 2017

1 reference

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

21 January 2018

1 reference

Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and management

21 January 2018

1 reference

HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.

21 January 2018

1 reference

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

21 January 2018

1 reference

Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma

21 January 2018

1 reference

Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis

21 January 2018

1 reference

SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.

21 January 2018

1 reference

Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model

21 January 2018

1 reference

Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

Performance of serum marker panels for liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis

21 January 2018

1 reference

Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts

21 January 2018

1 reference

High-throughput quantitative profiling of serum N-glycome by MALDI-TOF mass spectrometry and N-glycomic fingerprint of liver fibrosis.

21 January 2018

1 reference

Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours

21 January 2018

1 reference

Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation

21 January 2018

1 reference

Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer

21 January 2018

1 reference

Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures

21 January 2018

1 reference

Alterations in the serum glycome due to metastatic prostate cancer

21 January 2018

1 reference

Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics.

21 January 2018

1 reference

Glycome mapping on DNA sequencing equipment.

21 January 2018

1 reference

Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis.

21 January 2018

1 reference

N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus

21 January 2018

1 reference

The nomenclature of chronic hepatitis: time for a change.

21 January 2018

1 reference

Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review

21 January 2018

1 reference

Newer markers for hepatocellular carcinoma

21 January 2018

1 reference

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.

21 January 2018

1 reference

Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans

21 January 2018

1 reference

Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers

21 January 2018

1 reference

N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing

21 January 2018

1 reference

Detection of hepatocellular carcinoma using glycomic analysis

21 January 2018

1 reference

Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis.

21 January 2018

1 reference

Rating of CCl(4)-induced rat liver fibrosis by blood serum glycomics.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25030

1 reference

17 November 2017

1 reference